Biotech | May 06, 2022
Procter & Gamble Health posts 14 per cent growth in net profit in Q3
The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year
The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year
Ranked 25th with an impressive growth rate of 29% among Indian pharma companies in FY 2021-22
Demand for pharmacies contribute to 52% of the total searches, vaccination centres 30%
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
The report has estimated 4.74 million deaths for India in 2020 and 2021,
The study, presented at the European Stroke Organisation Conference (ESOC 2022) pinpointed specific groups of bacteria associated with poorer neurological recovery from ischaemic stroke both in the acute phase (24 hours) and after three months
Docosanol Cream, 10% (OTC) has an estimated market size of US$60 million for twelve months ending December 2021 according to IQVIA
Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions
Participants taking tirzepatide lost up to 52 lb. (24 kg) in this 72-week phase 3 study
The plant is expected to start commercial operations from Q4FY24
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
